Diabetic nephropathy
Role of Inflammation in the Pathogenesis of Diabetic Nephropathy
... Diabetic nephropathy remains the leading cause of increased morbidity and mortality and an urgent need exists to identify nov- el biomarkers and to develop new therapeutic ...of diabetic patients at ...
5
Dietary protein and the progression of diabetic nephropathy
... those diabetic patients destined to develop diabetic nephropathy to be identified up to 15 years before they presented with the full-blown clinical syndrome of persistent proteinuria, arterial ...
170
Rodent models of diabetic nephropathy: their utility and limitations
... advanced diabetic nephropathy, in part because there is no ideal model that exhibits all of the key histological features of human diabetic nephropathy, such as glomerular nodular lesions and ...
12
Nitric oxide system and diabetic nephropathy
... Endothelial dysfunction has also been shown to lead to an uncoupling of the vascular endothelial growth factor (VEGF)-nitric oxide axis resulting in enhanced proin- flammatory and proliferative effects of VEGF [36,37]. ...
6
Diabetic nephropathy : pathology, genetics and carnosine metabolism
... In chronic glomerulonephritis the higher number of leucine repeats in the CNDP1 gene seems to be involved in progression to ESRD and mortality on dialysis. There are two pathways by which this association can be ...
224
The Emerging Roles of Microparticles in Diabetic Nephropathy
... molecules. Diabetic nephropathy (DN) is currently the greatest contributor to end-stage renal diseases (ESRD) worldwide, and its public health impact will continue to grow due to the persistent increase in ...
8
Study of urinary cyclophilin a level in diabetic nephropathy
... Early studies suggested that approximately 80% of microalbuminuric type 1 diabetic patients would develop proteinuria [133-135]. However, more recent studies suggest that in approximately 30% of micro-albuminuric ...
123
Role of toll receptors in diabetic nephropathy
... human diabetic kidney suggesting a possible role for TLR4 but not TLR2 in mediating monocot/ma- crophage recruitment and tubulointerstitial inflammation in diabetic ...lacking nephropathy, nine ...
7
Structural functional relationships in diabetic nephropathy
... of diabetic nephropathy, albuminuria, hypertension, and decreased glomerular filtration rate related poorly or not at all to GBM ...of diabetic nephropathy, although in the absence of these ...
14
Diabetic Nephropathy - A Major Macrovascular Complication
... Diabetes mellitus (DM) is a complex, progressive disease, which is accompanied by multiple complications. One of the major complication confronted by patients with diabetes is an increased risk of developing ...
27
Diabetic nephropathy: early detection and therapeutic strategies
... and Diabetic Nephropathy (ASCEND) was ...overt nephropathy were randomised to receive the ET antagonist avosentan or placebo in addition to RAAS blockade for 6 ...of Diabetic ...
419
ROLE OF DYSLIPIDEMIA IN THE DEVELOPMENT AND PROGRESSION OF DIABETIC NEPHROPATHY
... of diabetic nephropathy determine the need for a detailed study of the mechanisms of renal disease chronization in diabetes mellitus (DM), search for triggers and markers of failure of renal adaptive ...
6
The relationship between obesity and diabetic nephropathy in China
... Overall, our study demonstrates that obesity is very com- mon among DN patients undergoing renal biopsy in China, which is associated with the most rapid increases in both obesity and diabetes globally. Obese patients ...
9
Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
... in diabetic and pre-diabetic nephropathy, suggesting that cystatin C may play major role in development of nephropathy in pre-diabetes ...2 diabetic pa- tients found that increased ...
7
Chinese medicines in the treatment of experimental diabetic nephropathy
... DN: diabetic nephropathy; ER: endoplasmic reticulum; ET‑1: endothelin‑1; ESRD: end‑stage renal disease; EMT: epithelial‑to‑mesenchymal transition; ECM: extracel‑ lular matrix; EMMPRIN: extracellular matrix ...
12
Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
... reversing diabetic nephropathy in streptozotocin (STZ)-induced type I diabetic ...in diabetic rats, while ICA II could reverse these ...
11
Therapeutic Modalities in Diabetic Nephropathy: Future Approaches
... PKC diabetic retinopathy study 2 (PKC-DRS 2) seemed to show an increased fre- quency of the adverse event of “diabetic nephropathy” in ruboxistaurin-treated patients compared with placebo- treated ...
14
Diabetic nephropathy
... Diabetic nephropathy is the leading cause of chronic renal disease and a major cause of cardiovascular ...mortality. Diabetic nephropathy has been categorized into stages: microalbuminuria and ...
17
Diabetic nephropathy – complications and treatment
... the diabetic milieu, metabolic derangements and hemodynamic alterations, particularly activation of the renin–angiotensin system, trigger a number of cell signaling cascades, including the MAPKs (p38 and JNK) and ...
21
Endothelial dysfunction and inflammation in diabetic nephropathy
... 1 diabetic mice. The severity of diabetic nephropathy was measured in diabetic mice that were transfected with the sFlt-1 gene 15 weeks after the induction of diabetes; these findings were ...
200